Gut-alzheimer-risk
Ontology highlight
ABSTRACT:
PROVIDER: PRJEB45904 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| ERR6121410_1.fastq.gz | Fastqsanger.gz | |||
| ERR6121410_2.fastq.gz | Fastqsanger.gz | |||
| ERR6121420_1.fastq.gz | Fastqsanger.gz | |||
| ERR6121420_2.fastq.gz | Fastqsanger.gz | |||
| ERR6121430_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 192 |
Similar Datasets
Project description:Polygenic risk scores have identified that genetic variants without genome-wide significance still add to the genetic risk of developing Alzheimer’s disease (AD). Whether and how subthreshold risk loci translate into relevant disease pathways, is unknown. We investigate here the involvement of AD risk variants in the transcriptional responses of two mouse models: APPswe/PS1L166P and Thy-TAU22. A unique gene expression module, highly enriched for AD risk genes, is specifically responsive to Aβ but not TAU pathology. We identify in this module 7 established AD risk genes (APOE, CLU, INPP5D, CD33, PLCG2, SPI1 and FCER1G) and 11 AD GWAS genes below the genome-wide significance threshold (GPC2, TREML2, SYK, GRN, SLC2A5, SAMSN1, PYDC1, HEXB, RRBP1, LYN and BLNK), that become significantly upregulated when exposed to Aβ. Single microglia sequencing confirms that Aβ, not TAU, pathology induces marked transcriptional changes in microglia, including increased proportions of activated microglia. We conclude that genetic risk of AD functionally translates into different microglia pathway responses to Aβ pathology, placing AD genetic risk downstream of the amyloid pathway but upstream of TAU pathology.
2020-01-14 | GSE142267 | GEO
Project description:Polygenic risk scores have identified that genetic variants without genome-wide significance still add to the genetic risk of developing Alzheimer’s disease (AD). Whether and how subthreshold risk loci translate into relevant disease pathways, is unknown. We investigate here the involvement of AD risk variants in the transcriptional responses of two mouse models: APPswe/PS1L166P and Thy-TAU22. A unique gene expression module, highly enriched for AD risk genes, is specifically responsive to Aβ but not TAU pathology. We identify in this module 7 established AD risk genes (APOE, CLU, INPP5D, CD33, PLCG2, SPI1 and FCER1G) and 11 AD GWAS genes below the genome-wide significance threshold (GPC2, TREML2, SYK, GRN, SLC2A5, SAMSN1, PYDC1, HEXB, RRBP1, LYN and BLNK), that become significantly upregulated when exposed to Aβ. Single microglia sequencing confirms that Aβ, not TAU, pathology induces marked transcriptional changes in microglia, including increased proportions of activated microglia. We conclude that genetic risk of AD functionally translates into different microglia pathway responses to Aβ pathology, placing AD genetic risk downstream of the amyloid pathway but upstream of TAU pathology.
2020-01-14 | GSE110741 | GEO
Project description:The blood-brain barrier (BBB) is a highly selective interface that traditionally has been seen as restricting blood-borne substances from entering the brain. Despite its essential role in brain health and disease, the extent and functional impact of physiological blood-to-brain protein transport remain largely unexplored. Here, we use a combination of bioorthogonal chemistries, blood proteome labeling, and mass spectrometry to discover the repertoire of BBB-permeable proteins in healthy mice. We discovered that the brain vasculature actively samples hundreds of diverse circulatory proteins under physiological conditions. Many of these proteins accumulate in the brain, showing distinct enrichment patterns across both functional protein classes and anatomical brain regions. In models of neuroinflammatory and neurodegenerative diseases, the composition of BBB-permeable proteins changed significantly, implicating dysregulated protein transport in disease pathogenesis. Notably, single-injection validation experiments revealed that BBB-permeable proteins exhibit cell type-specific targeting to neurons, astrocytes, or microglia, suggesting specialized functional roles. Focusing on apolipoprotein A1 (APOA1), we demonstrate its entry via brain endothelial SCARB1 receptor, its selective accumulation in astrocytes and its interaction with the ABCA1 receptor—a critical AD risk gene that also binds APOE, the strongest genetic risk factor for late-onset Alzheimer's disease. This peripheral-central interaction promotes cholesterol efflux in astrocytes and protects neuronal synapses from degeneration. Overall, our study redefines the BBB as a dynamic conduit for the transport of specific, neuroprotective circulatory proteins into the healthy brain and establishes a molecular link between peripheral factors and Alzheimer's risk genes.
2026-07-03 | GSE301832 | GEO
Project description:The blood-brain barrier (BBB) is a highly selective interface that traditionally has been seen as restricting blood-borne substances from entering the brain. Despite its essential role in brain health and disease, the extent and functional impact of physiological blood-to-brain protein transport remain largely unexplored. Here, we use a combination of bioorthogonal chemistries, blood proteome labeling, and mass spectrometry to discover the repertoire of BBB-permeable proteins in healthy mice. We discovered that the brain vasculature actively samples hundreds of diverse circulatory proteins under physiological conditions. Many of these proteins accumulate in the brain, showing distinct enrichment patterns across both functional protein classes and anatomical brain regions. In models of neuroinflammatory and neurodegenerative diseases, the composition of BBB-permeable proteins changed significantly, implicating dysregulated protein transport in disease pathogenesis. Notably, single-injection validation experiments revealed that BBB-permeable proteins exhibit cell type-specific targeting to neurons, astrocytes, or microglia, suggesting specialized functional roles. Focusing on apolipoprotein A1 (APOA1), we demonstrate its entry via brain endothelial SCARB1 receptor, its selective accumulation in astrocytes and its interaction with the ABCA1 receptor—a critical AD risk gene that also binds APOE, the strongest genetic risk factor for late-onset Alzheimer's disease. This peripheral-central interaction promotes cholesterol efflux in astrocytes and protects neuronal synapses from degeneration. Overall, our study redefines the BBB as a dynamic conduit for the transport of specific, neuroprotective circulatory proteins into the healthy brain and establishes a molecular link between peripheral factors and Alzheimer's risk genes.
2026-07-03 | GSE301830 | GEO
Project description:The blood-brain barrier (BBB) is a highly selective interface that traditionally has been seen as restricting blood-borne substances from entering the brain. Despite its essential role in brain health and disease, the extent and functional impact of physiological blood-to-brain protein transport remain largely unexplored. Here, we use a combination of bioorthogonal chemistries, blood proteome labeling, and mass spectrometry to discover the repertoire of BBB-permeable proteins in healthy mice. We discovered that the brain vasculature actively samples hundreds of diverse circulatory proteins under physiological conditions. Many of these proteins accumulate in the brain, showing distinct enrichment patterns across both functional protein classes and anatomical brain regions. In models of neuroinflammatory and neurodegenerative diseases, the composition of BBB-permeable proteins changed significantly, implicating dysregulated protein transport in disease pathogenesis. Notably, single-injection validation experiments revealed that BBB-permeable proteins exhibit cell type-specific targeting to neurons, astrocytes, or microglia, suggesting specialized functional roles. Focusing on apolipoprotein A1 (APOA1), we demonstrate its entry via brain endothelial SCARB1 receptor, its selective accumulation in astrocytes and its interaction with the ABCA1 receptor—a critical AD risk gene that also binds APOE, the strongest genetic risk factor for late-onset Alzheimer's disease. This peripheral-central interaction promotes cholesterol efflux in astrocytes and protects neuronal synapses from degeneration. Overall, our study redefines the BBB as a dynamic conduit for the transport of specific, neuroprotective circulatory proteins into the healthy brain and establishes a molecular link between peripheral factors and Alzheimer's risk genes.
2026-07-03 | GSE301828 | GEO
Project description:The blood-brain barrier (BBB) is a highly selective interface that traditionally has been seen as restricting blood-borne substances from entering the brain. Despite its essential role in brain health and disease, the extent and functional impact of physiological blood-to-brain protein transport remain largely unexplored. Here, we use a combination of bioorthogonal chemistries, blood proteome labeling, and mass spectrometry to discover the repertoire of BBB-permeable proteins in healthy mice. We discovered that the brain vasculature actively samples hundreds of diverse circulatory proteins under physiological conditions. Many of these proteins accumulate in the brain, showing distinct enrichment patterns across both functional protein classes and anatomical brain regions. In models of neuroinflammatory and neurodegenerative diseases, the composition of BBB-permeable proteins changed significantly, implicating dysregulated protein transport in disease pathogenesis. Notably, single-injection validation experiments revealed that BBB-permeable proteins exhibit cell type-specific targeting to neurons, astrocytes, or microglia, suggesting specialized functional roles. Focusing on apolipoprotein A1 (APOA1), we demonstrate its entry via brain endothelial SCARB1 receptor, its selective accumulation in astrocytes and its interaction with the ABCA1 receptor—a critical AD risk gene that also binds APOE, the strongest genetic risk factor for late-onset Alzheimer's disease. This peripheral-central interaction promotes cholesterol efflux in astrocytes and protects neuronal synapses from degeneration. Overall, our study redefines the BBB as a dynamic conduit for the transport of specific, neuroprotective circulatory proteins into the healthy brain and establishes a molecular link between peripheral factors and Alzheimer's risk genes.
2026-07-03 | GSE301825 | GEO
Project description:(Epi)genetic risk architectures of opioid dependent brain
| PRJNA787001 | ENA
Project description:(Epi)genetic risk architectures of opioid dependent brain
| PRJNA787000 | ENA
Project description:Neuropsychiatric disorders are highly complex conditions and the risk of developing a disorder has been tied to hundreds of genomic variants that alter the expression and/or products (isoforms) made by risk genes. However, how these genes contribute to disease risk and onset through altered expression and RNA splicing is not well understood. Here we show our current understanding of gene isoforms is far from complete and reveal the precise splicing profiles of neuropsychiatric disorder risk genes. Combining our new bioinformatic pipeline IsoLamp with nanopore long-read amplicon sequencing, we deeply profiled the RNA isoform repertoire of 31 high-confidence neuropsychiatric disorder risk genes in human brain. We show most risk genes are more complex than previously reported, identifying 443 novel isoforms and 28 novel exons, including isoforms which alter protein domains, and genes such as ATG13 and GATAD2A where most expression was from previously undiscovered isoforms. The greatest isoform diversity was present in the schizophrenia risk gene ITIH4. Mass spectrometry of brain protein isolates confirmed translation of a novel exon skipping event in ITIH4, suggesting a new regulatory mechanism for this gene in brain
2025-07-25 | PXD063836 | Pride